A double-blind placebo controlled study of 1g, 2g and 4g V0251 efficacy and tolerance in vestibular neuritis
A double-blind placebo controlled study of 1g, 2g and 4g V0251 efficacy and tolerance in vestibular neuritis
A double-blind placebo controlled study of 1g, 2g and 4g V0251 efficacy and tolerance in vestibular neuritis
Status
Status :
Completed
Type of study
Phase II
Min. Age
18
Years old
Max. Age
-
Gender
All
Therapeutic area :
Central Nervous System
Disease :
Osteoarthritis
Study medication :
V0251 (L-acetylleucine)
Phase :
Phase II
Start Date :
13 April 2008
End date :
19 April 2010
Study ID :
V00251 IV 201
EudraCT/CTIS number :
2007-005054-23
Send by email